Weed (BUDZ) Free Cash Flow (2010 - 2026)
Weed's (BUDZ) quarterly Free Cash Flow came in at -$57737.0 in Q1 2026, up 19.63% year-on-year from -$48263.4 in Q1 2025, and up 51.75% quarter-over-quarter from -$119665.0 in Q4 2025.
Weed (BUDZ) Free Cash Flow (2010 - 2026) Analysis & Trends
Weed's Free Cash Flow history runs 13 years deep, the most recent figure standing at -$57737.0 for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 19.63% year-over-year to -$57737.0 in Q1 2026; TTM through Mar 2026 was -$181035.0, a 41.53% increase from a year earlier, with the FY2025 full-year figure at -$195136.0, up 53.04% from the prior year.
- Free Cash Flow improved to -$57737.0 in Q1 2026 per BUDZ's latest filing, from -$119665.0 in the prior quarter.
- Across five years, Free Cash Flow topped out at $1319.0 in Q2 2025 and bottomed at -$451204.0 in Q3 2023.
- The 5-year median for Free Cash Flow is -$127445.0 (2024), against an average of -$150909.4.
- Across the five-year window, Free Cash Flow tumbled 194.13% in 2022 and surged 101.61% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$180268.0 in 2022, then tumbled by 88.54% to -$339885.0 in 2023, then jumped by 62.5% to -$127445.0 in 2024, then rose by 6.1% to -$119665.0 in 2025, then surged by 51.75% to -$57737.0 in 2026.
- Per Business Quant, the three latest BUDZ Free Cash Flow figures stand at -$57737.0 (Q1 2026), -$119665.0 (Q4 2025), and -$4952.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -57,737.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57,737.00 |
| Mar 31, 2026 | -57,737.00 |
| Dec 31, 2025 | -119,665.00 |
| Dec 31, 2025 | -119,665.00 |
| Sep 30, 2025 | -4,952.00 |
| Sep 30, 2025 | -4,952.00 |
| Jun 30, 2025 | 1,319.00 |
| Jun 30, 2025 | 1,319.00 |
| Mar 31, 2025 | -71,838.00 |
| Mar 31, 2025 | -71,838.00 |
| Dec 31, 2024 | -127,445.00 |
| Dec 31, 2024 | -127,445.00 |
| Sep 30, 2024 | -28,628.00 |
| Sep 30, 2024 | -28,628.00 |
| Jun 30, 2024 | -81,721.00 |
| Jun 30, 2024 | -81,721.00 |
| Mar 31, 2024 | -177,730.00 |
| Mar 31, 2024 | -177,730.00 |
| Dec 31, 2023 | -339,885.00 |
| Dec 31, 2023 | -339,885.00 |